Literature DB >> 27920630

Bilateral Diffuse Pseudoangiomatous Stromal Hyperplasia (PASH) Causing Gigantomastia in a 33-Year-Old Pregnant Woman: Case Report.

Natalia Krawczyk1, Tanja Fehm1, Eugen Ruckhäberle1, Svjetlana Mohrmann1, Jasmin Riemer2, Stefan Braunstein2, Jürgen Hoffmann1.   

Abstract

Pseudoangiomatous stromal hyperplasia (PASH) is a benign proliferation of mammary stroma mostly described as an incidental microscopic finding. Clinically, it can manifest as a palpable, well-circumscribed breast mass or in rare cases as a diffuse bilateral process causing massive breast enlargement. The most postulated theory for aetiology of this condition is hormonal stimulation of mammary myofibroblasts, particularly by progesterone. A definite diagnosis of PASH is based on typical pathological findings like stromal hyperplasia and empty slit-like channels positive for myofibroblastic and negative for endothelial markers. The main clinical differential diagnosis is a fibroadedoma or phylloid tumour, and histologically a low-grade angiosarcoma. There are less than 200 cases of tumorous PASH and less than 20 of diffuse PASH reported so far. Here we present a case report of huge diffuse PASH, that is, to our knowledge, the first in a pregnant woman.

Entities:  

Keywords:  Breast; Diffuse pseudoangiomatous stromal hyperplasia; Mastectomy; PASH; Pregnancy

Year:  2016        PMID: 27920630      PMCID: PMC5123024          DOI: 10.1159/000450867

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  14 in total

1.  Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum.

Authors:  R E Ibrahim; C G Sciotto; N Weidner
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

2.  Tamoxifen in the management of pseudoangiomatous stromal hyperplasia.

Authors:  S Pruthi; C Reynolds; R E Johnson; J J Gisvold
Journal:  Breast J       Date:  2001 Nov-Dec       Impact factor: 2.431

3.  Pseudoangiomatous stromal hyperplasia and breast cancer risk.

Authors:  Amy C Degnim; Marlene H Frost; Derek C Radisky; Stephanie S Anderson; Robert A Vierkant; Judy C Boughey; V Shane Pankratz; Karthik Ghosh; Lynn C Hartmann; Daniel W Visscher
Journal:  Ann Surg Oncol       Date:  2010-06-22       Impact factor: 5.344

4.  Rapidly growing bilateral pseudoangiomatous stromal hyperplasia of the breast.

Authors:  Eun Mi Ryu; In Yong Whang; Eun Deok Chang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

5.  Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation.

Authors:  Katie N Jones; Katrina N Glazebrook; Carol Reynolds
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

6.  Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation.

Authors:  C M Powell; M L Cranor; P P Rosen
Journal:  Am J Surg Pathol       Date:  1995-03       Impact factor: 6.394

7.  Pseudoangiomatous stromal hyperplasia. A case for bilateral mastectomy in a 12-year-old girl.

Authors:  Kimberly A Singh; Melinda M Lewis; Robyn L Runge; Grant W Carlson
Journal:  Breast J       Date:  2007 Nov-Dec       Impact factor: 2.431

8.  Pseudoangiomatous hyperplasia of mammary stroma.

Authors:  M F Vuitch; P P Rosen; R A Erlandson
Journal:  Hum Pathol       Date:  1986-02       Impact factor: 3.466

9.  Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma.

Authors:  C Anderson; A Ricci; C A Pedersen; R W Cartun
Journal:  Am J Surg Pathol       Date:  1991-02       Impact factor: 6.394

10.  Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases.

Authors:  Marco Ferreira; Constance T Albarracin; Erika Resetkova
Journal:  Mod Pathol       Date:  2007-12-14       Impact factor: 7.842

View more
  4 in total

Review 1.  A Systematic Literature Review of the Clinical Presentation, Management, and Outcome of Gestational Gigantomastia in the 21st Century.

Authors:  Nawaf Alhindi; Hatan Mortada; Wasan Alzaid; Abdullah A Al Qurashi; Basim Awan
Journal:  Aesthetic Plast Surg       Date:  2022-08-08       Impact factor: 2.708

2.  Pseudoangiomatous stromal hyperplasia presenting as an axillary mass in a postmenopausal woman undergoing in vitro fertilization.

Authors:  Jesse Liu; Megan Casady; Kristen Paral; Jennifer Powers
Journal:  JAAD Case Rep       Date:  2019-01-25

3.  Idiopathic gigantomastia in a patient on polypharmacy.

Authors:  Ngoc-Nhu Jennifer Nguyen; Lilia Maria Sanchez; Mariam Yassa; Julie David; Mona El Khoury
Journal:  BJR Case Rep       Date:  2021-06-09

4.  Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: An Uncommon Finding in an Uncommon Patient.

Authors:  Alessandra Surace; Viola Liberale; Marta D'Alonzo; Silvia Pecchio; Maria Grazia Baù; Nicoletta Biglia
Journal:  Am J Case Rep       Date:  2020-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.